文献速递造血干细胞移植与细胞治疗淋巴瘤

急性移植物抗宿主病中的微生物组-肠道交互对话

Microbiome-intestine cross talk during acute graft-versus-host disease.
PubMed 文献 · Blood · 2020-01-01

异基因造血干细胞移植(allo-SCT)可治愈多种疾病但并发移植物抗宿主病(GVHD)和感染限制其应用。微生物组研究进展促进了对人类肠道菌群及其与宿主免疫系统在allo-SCT和移植后并发症中相互作用的理解。越来越多证据表明allo-SCT后常发生共生微生物组失调,这种失调可易感不良临床结局,尤其包括急性肠道GVHD和总生存期降低。本综述讨论微生物组与免疫系统组分在急性肠道GVHD炎症状态通路中的相互作用,以及已设计或正在研究的以微生物组为中心改善allo-SCT患者急性肠道GVHD结局的策略。

要点

  • allo-SCT后常发生肠道共生微生物组失调,与急性肠道GVHD和总生存期降低相关
  • 微生物组与免疫系统组分相互作用参与急性肠道GVHD炎症通路
  • 已有或正在研究以微生物组为中心的策略以改善allo-SCT患者急性肠道GVHD结局

核心结论

  • allo-SCT后共生微生物组常失调,可易感不良临床结局,尤其急性肠道GVHD和总生存期降低;微生物组与免疫系统相互作用参与急性肠道GVHD炎症通路。

研究设计与样本

  • 综述,讨论微生物组与免疫系统组分在急性肠道GVHD中的相互作用及以微生物组为中心的策略。

主要发现

  • allo-SCT后共生微生物组常失调,可易感不良临床结局,尤其急性肠道GVHD和总生存期降低。
  • 综述讨论了微生物组与免疫系统组分在急性肠道GVHD炎症通路中的相互作用。
  • 综述讨论了已设计或正在研究的以微生物组为中心改善allo-SCT患者急性肠道GVHD结局的策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic hematopoietic stem cell transplantation (allo-SCT) offers cure for a variety of conditions, in particular, but not limited to, hematologic malignancies. However, it can be associated with life-threatening complications, including graft-versus-host disease (GVHD) and infections, which are factors limiting its widespread use. Technical advances in the field of microbiome research have allowed for a better understanding of the microbial flora of the human intestine, as well as dissection of their interactions with the host immune system in allo-SCT and posttransplant complications. There is growing evidence that the commensal microbiome is frequently dysregulated following allo-SCT and that this dysbiosis can predispose to adverse clinical outcomes, especially including acute intestinal GVHD and reduced overall survival. In this review, we discuss the interactions between the microbiome and the components of the immune system that play a major role in the pathways leading to the inflammatory state of acute intestinal GVHD. We also discuss the microbiome-centered strategies that have been devised or are actively being investigated to improve the outcomes of allo-SCT patients in regard to acute intestinal GVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood. 2020. PMID: 32526029. doi:10.1182/blood.2019000950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。